Company: CERO
Filing Date: 2025-05-27
Form Type: POS AM
Source: 0001213900-25-047469
Chunk: 139

Company: CERO THERAPEUTICS HOLDINGS, INC.
Filing Date: 2025-05-27
Form: POS AM
Chunk 139
---
, we intend to invest the net proceeds to us in investment-grade, interest-bearing securities such as money market funds, certificates of deposit, or direct or guaranteed obligations of the U.S. government, or hold as cash. We cannot predict whether the net proceeds invested will yield a favorable return. Keystone is not obligated to buy any Common Stock under the Keystone Purchase Agreements if such shares, when aggregated with all other Common Stock then beneficially owned by Keystone and its respective affiliates (as calculated pursuant to Section 13(d) of the Exchange Act and Rule 13d-3 promulgated thereunder), would result in Keystone beneficially owning Common Stock in excess of 4.99% of the then-outstanding shares of Common Stock (the “Beneficial Ownership Limitation”). Concurrent with the execution of the Keystone Purchase Agreements, we entered into the Keystone Registration Rights Agreements, pursuant to which we agreed to provide Keystone with customary registration rights related to the shares issued under the Keystone Purchase Agreements. The Keystone Purchase Agreements and Keystone Registration Rights Agreements contain customary registration rights, representations, warranties, conditions and indemnification obligations by each party. The representations, warranties and covenants contained in such agreements were made only for purposes of such agreements and as of specific dates, were solely for the benefit of the parties to such agreements and are subject to certain important limitations. Keystone Purchase Agreements and Registration Statements In February 2024, we entered into the February 2024 Keystone Purchase Agreement with Keystone, pursuant to which we may sell and issue, and Keystone is obligated to purchase, up to $25,000,000 of shares of Common Stock; provided that the number of shares issued pursuant to the February 2024 Keystone Purchase Agreement shall not exceed 250,000 shares (the “Initial Limit”). In accordance with our obligations under the November 2024 Keystone Purchase Agreement and the November 2024 Keystone Registration Rights Agreement, we previously filed the Prior Registration Statement in order to register the resale of up to: (i) 250,000 Keystone Purchase Shares that we may elect, in our sole discretion, to issue and sell to Keystone, from time to time from and after the Keystone Commencement Date upon the terms and subject to the conditions and limitations of the February 2024 Keystone Purchase Agreement, subject to applicable stock exchange rules (assuming the shares are sold at a price of $1.00 per share) and (ii) 6,190 Keystone Commitment Shares that have been issued to Keystone as consideration for its execution and